Valuation: Shandong Pharmaceutical Glass Co.Ltd

Capitalization 13.6B 1.93B 1.64B 1.54B 1.44B 2.66B 175B 2.9B 17.91B 6.92B 82.42B 7.24B 7.09B 300B P/E ratio 2025 *
18.8x
P/E ratio 2026 * 12.5x
Enterprise value 9.93B 1.41B 1.2B 1.12B 1.05B 1.94B 128B 2.12B 13.07B 5.05B 60.16B 5.29B 5.18B 219B EV / Sales 2025 *
2.21x
EV / Sales 2026 * 1.56x
Free-Float
79.37%
Yield 2025 *
2.82%
Yield 2026 * 2.93%
More valuation ratios * Estimated data
Dynamic Chart
Oct. 27 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
Aug. 25 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2025 CI
Apr. 24 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
24-10-28 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
24-08-27 Shandong Pharmaceutical Glass' H1 Profit Jumps 23%, Operating Income Up 7%; Shares Soar 10% MT
24-08-26 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2024 CI
24-04-22 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
23-10-18 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
23-08-28 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
23-04-24 Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-04-24 Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-11-28 Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 billion in funding CI
22-10-28 Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
More news
1 day+2.19%
1 week+1.84%
Current month+1.84%
1 month-3.94%
3 months-6.90%
6 months-5.14%
Current year-20.45%
More quotes
1 week 19.95
Extreme 19.95
20.57
1 month 19.9
Extreme 19.9
21.33
Current year 19.9
Extreme 19.9
27.25
1 year 19.9
Extreme 19.9
28.34
3 years 19.9
Extreme 19.9
32.33
5 years 18.63
Extreme 18.63
53.14
10 years 6.81
Extreme 6.8112
76.85
More quotes
Manager TitleAgeSince
Chief Executive Officer 55 2020-01-06
Director of Finance/CFO 51 2013-05-10
Corporate Officer/Principal 53 1988-12-31
Director TitleAgeSince
Chairman 60 2019-05-12
Director/Board Member 55 2004-03-19
Director/Board Member 48 2013-05-10
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.19%+1.84%-20.91%-27.12% 1.93B
+0.58%+4.36%-4.53%+27.12% 3.55B
-0.74%+3.69%+1.86%-21.57% 3.37B
+1.04%+10.47%+36.93%-3.64% 2.4B
+1.35%+0.67%-21.36%-47.48% 769M
+0.68%+4.16%+3.31%+21.05% 587M
-3.39%-0.11%+72.59%+36.27% 508M
+2.87%+2.97%-20.43%-40.29% 500M
+0.57%-4.60%+5.64%-14.40% 418M
Average +0.57%+1.57%+5.90%-7.79% 1.56B
Weighted average by Cap. +0.55%+3.28%+3.77%-4.95%
See all sector performances

Financials

2025 *2026 *
Net sales 4.5B 639M 543M 508M 477M 879M 57.93B 961M 5.92B 2.29B 27.27B 2.4B 2.35B 99.17B 5.9B 837M 711M 666M 625M 1.15B 75.89B 1.26B 7.76B 3B 35.72B 3.14B 3.07B 130B
Net income 725M 103M 87.52M 81.89M 76.91M 142M 9.34B 155M 955M 369M 4.39B 386M 378M 15.98B 1.09B 155M 132M 123M 116M 213M 14.05B 233M 1.44B 555M 6.61B 581M 569M 24.04B
Net Debt -3.67B -521M -443M -415M -390M -718M -47.29B -784M -4.84B -1.87B -22.26B -1.96B -1.91B -80.95B -4.43B -628M -534M -500M -470M -865M -57.01B -945M -5.83B -2.25B -26.83B -2.36B -2.31B -97.58B
More financial data * Estimated data
Logo Shandong Pharmaceutical Glass Co.Ltd
Shandong Pharmaceutical Glass Co Ltd is a China-based company mainly engaged in the research and development, production and sales of various pharmaceutical glass bottle products. The Company operates five segments, including Packaging Products segment, Trading segment, Barreled Water segment, Logistics segment, and Service segment. The Company’s main glass bottle products include molded bottle series products, brown bottle series products, ampoules, and tube bottles. The Company’s products also include butyl rubber plug products, aluminum-plastic caps, plastic bottle products, and others. The Company's products are widely used in the packaging of various products such as medicines, health products, and cosmetics. The Company mainly conducts businesses within the domestic market.
Employees
7,116
More about the company
Date Price Change Volume
25-12-15 20.50 ¥ +2.19% 11,762,130
25-12-12 20.06 ¥ -0.79% 14,827,540
25-12-11 20.22 ¥ +0.70% 8,957,760
25-12-10 20.08 ¥ -0.25% 4,682,040
25-12-09 20.13 ¥ 0.00% 4,156,215

End-of-day quote Shanghai S.E., December 14, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
20.50CNY
Average target price
30.28CNY
Spread / Average Target
+47.68%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600529 Stock